Quantcast
Last updated on April 16, 2014 at 8:29 EDT

Latest Neuroprosthetics Stories

2013-12-03 12:26:02

ALBANY, New York, December 3, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Cardiac Prosthetic Devices Market (Mechanical Heart Valves, Tissue Heart Valves, Transcatheter Heart Valves, Implantable Pacemaker and External Pacemaker)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global cardiac prosthetic devices market was valued at USD 2,945.3million in 2012 and is estimated to reach a...

2013-12-02 23:00:23

Heart specialists at the Washington University and Barnes-Jewish Heart & Vascular Center were the first in Missouri to implant a subcutaneous implantable cardioverter defibrillator (S-ICD) into a patient during a procedure that took place on Friday, Nov. 29. Unlike the traditional ICD used to help treat arrhythmias such as tachycardia, the S-ICD does not place wires inside the heart or blood vessels. St. Louis (PRWEB) December 02, 2013 Heart specialists at the Washington University...

2013-12-01 20:21:19

- Acquisition expands HeartWare's technology platform into partial support for less sick patients - FRAMINGHAM, Mass. and TEANECK, N.J., Dec. 1, 2013 /PRNewswire/ -- HeartWare International, Inc. (Nasdaq: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it has acquired CircuLite(®), Inc. - developer of the SYNERGY(®) Circulatory Support System, designed to treat...

2013-11-26 16:24:25

A "Bionic Eye" for Leading Cause of Blindness in Americans Over Age 65 WASHINGTON, Nov. 26, 2013 /PRNewswire-USNewswire/ -- A tiny device is making a big difference in the lives of people with end-stage macular degeneration (AMD), the leading cause of blindness in people over the age of 65 according to the Centers for Disease Control and Prevention. (Photo: http://photos.prnewswire.com/prnh/20131126/DC19365) "Macular degeneration is a disease of the retina where there is a change...

2013-11-25 04:20:51

PARIS, November 25, 2013 /PRNewswire/ -- Funds to advance development of retinal implant systems that aim to restore vision in blind people Financing includes Bpifrance, through the InnoBio fund Pixium Vision ("Pixium"), a developer of innovative retinal implant systems that aim to restore vision in the blind, has closed a EUR15 million Series A extension financing. This round was led by Sofinnova Partners,...

2013-11-21 11:33:22

UT Dallas researchers have demonstrated that treating tinnitus, or ringing in the ears, using vagus nerve stimulation-tone therapy is safe and brought significant improvement to some of the participants in a small clinical trial. Drs. Sven Vanneste and Michael Kilgard of the School of Behavioral and Brain Sciences used a new method pairing vagus nerve stimulation (VNS) with auditory tones to alleviate the symptoms of chronic tinnitus. Their results were published on Nov. 20 in the...

2013-11-19 12:29:28

DUBLIN, Ireland, November 19, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/m7rk4g/audiological) has announced the addition of the "Audiological Devices - Global Strategic Business Report" [http://www.researchandmarkets.com/research/m7rk4g/audiological ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report analyzes the worldwide markets for Audiological Devices...

2013-11-19 04:23:26

First System To Selectively Stimulate Targeted Areas Of The Brain To Manage Symptoms of Debilitating Disease NATICK, Massachusetts, November 19, 2013 /PRNewswire/ -- The Boston Scientific Corporation (NYSE: BSX) Vercise(TM) Deep Brain Stimulation (DBS) System has received CE Mark approval for the treatment of intractable primary and secondary dystonia, a neurological movement disorder characterized by involuntary muscle contractions. Dystonia affects more than 500,000...

2013-11-18 13:06:52

Retinal implant system research provides positive results for people with genetic eye disease Research presented today at the 117th Annual Meeting of the American Academy of Ophthalmology shows promising data about a device that helps people who have lost their vision due to a blinding genetic disease to recognize common objects. In the study, the researchers found when the objects' outlines had been enhanced, there was increased recognition. The device, called the Argus II, is the first...

2013-11-18 08:29:56

Dr. Katarina Stingl Shares Work on CE Marked Subretinal Implant Technology During the Young Ophthalmologists Session NEW ORLEANS, Nov. 18, 2013 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that Dr. Katarina Stingl, clinical scientist from the Centre for Ophthalmology, University of Tuebingen, Germany presented results from the Company sponsored clinical trial that led to CE mark of...